Composition for the prevention and/or treatment of cardiovascular diseases
There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment thereof. The cardiovascular diseases (CVD) may comprise several diseases associated with inflammation of the heart or arteries and include coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack), atherosclerosis, stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.
1. A method for treating cardiovascular diseases (CVD) in a subject in need thereof, comprising administering to said subject an effective amount of a thylakoid extract comprising purified functional photosynthetic pigments in their thylakoid membrane environment, in admixture with a physiologically acceptable carrier, wherein said amount of extract is about 0.00005 to about 500 mg per Kg of the subject's body weight.
2. The method of claim 1 , wherein said extract is stabilized in a medium comprising less than 10% of electron donor.
3. The method of claim 2 , wherein said medium comprises less than 10% of water.
4. The method of claim 1 , wherein said extract is for oral administration.
5. The method of claim 1 , wherein said extract is formulated for parenteral administration.
6. The method of claim 1 , wherein said extract is formulated intra-cardiac administration immediately after a heart attack.
7. The method of claim 1 , wherein said extract is formulated intra-cardiac administration up to 24 hours after a heart attack.
8. The method of claim 1 , wherein said CVD is selected from: angina, stroke, myocardial/cerebral infraction, atherosclerosis, bypass surgery, ischemia, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.
9. The method of claim 8 , wherein said CVD is angina, stroke, myocardial infraction, ischemia, venous thrombosis and atherosclerosis.
10. The method of claim 1 , wherein said amount of extract is about 0.05 to about 10 mg per Kg of subject's body weight.
11. The method of claim 1 , wherein the extract is in a dosage selected from: about 125 mg, about 200 mg, about 250 mg, about 500 and 1000 mg per day.